The galectin-7 enhances cisplatin-induced apoptosis in cervical cancer by promoting mitochondrial dysfunction and ROS generation, while reducing chemoresistance by facilitating stress granule clearance via the galectin-7/RACK1/G3BP1 axis. The gene discussed is RACK1; the disease is cervical cancer.